Top Pharmaceutical Companies Trust PharmaLegacy For Their Bone Metastasis Studies

Creating novel bone and orthopedics models needs no justification in a world where new pathologies are constantly appearing and even evolving, especially when a large number of cancers metastasize to the bones. Be it melanomas, breast cancer, or colon cancer, once a tumor finds its way to a patient’s bones, survival rates drop dramatically. More than 100,000 cases of bone metastasis are diagnosed every year, which further calls for the hasty development of new treatment methods. Download the brochure to learn more about our Bone Metastasis Models.